Real life analysis BV use as consolidation therapy in HL with high risk post ASCT Group Lymphoma Working Party (LWP) Principal investigator Mariana Bastos Oreiro
Outcomes of Allogeneic HCT in patients with Hodgkin Lymphoma in the era of Checkpoint Inhibitors: A joint CIBMTR and EBMT analysis. Group Lymphoma Working Party (LWP) Principal investigator Miguel-Angel Perales
A prospective study on the use of Brentuximab Vedotin or Checkpoint inhibitors as bridge to autologous stem cell transplantation in Hodgkin lymphoma Diseases Group Lymphoma Working Party (LWP) Principal investigator Ali Bazarbachi
Allogeneic Stem Cell TransplantationIn NK/ T-cell lymphoma Diseases Group Lymphoma Working Party (LWP) Principal investigator Norbert Schmitz
Comparison of allogeneic hematopoietic stem cell transplantation with chimeric antigen receptor T-cells in relapsed and refractory diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma Diseases Group Lymphoma Working Party (LWP) Type of Stem Cell Treatment Principal investigator Bertram Glass
A comparison between ATG and PT-CY graft-versus-host-disease prophylaxis in patients with lymphoma undergoing reduced intensity conditioning regimen HSCT from 1 antigen MMUD Diseases Group Lymphoma Working Party (LWP) Principal investigator Annalisa Paviglianiti
Outcomes of patients treated with Ibrutinib post autologous stem cell transplant for mantle cell lymphoma. Group Lymphoma Working Party (LWP) Principal investigator Steve Robinson / Claire Burney
LYM1: Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation Group Lymphoma Working Party (LWP) Type of Stem Cell Treatment Principal investigator Ruth Pettengell
Long Term Outcome of a Second Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma: A Retrospective Analysis from the Lymphoma Working Party of EBMT Group Lymphoma Working Party (LWP) Type of Stem Cell Treatment Principal investigator
Checkpoint inhibition for treating Hodgkin and Non-Hodgkin lymphoma in the context of allogeneic stem cell transplantation: A survey-based registry study of the EBMT Lymphoma Working Party. Group Lymphoma Working Party (LWP) Type of Stem Cell Treatment Principal investigator
Stem Cell Transplantation in blastic plasmocytoid dendritic cell neoplasia. A joint NIS with the ALWP Group Lymphoma Working Party (LWP) Type of Stem Cell Treatment Principal investigator Sascha Dietrich, Peter Dreger
Allogeneic Stem Cell Transplantation for cutaneous T-cell lymphoma Group Lymphoma Working Party (LWP) Type of Stem Cell Treatment Principal investigator Rafael Duarte